Alzheimer amyloid β-peptide A-β25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation

Annals of the New York Academy of Sciences

Volumn 1097, Issue , 2007, Pages 58-63

  Bisel, Blaine E ^a   Henkins, Kristen M ^a   Parfitt, Karen D ^a  

^a POMONA COLLEGE   (United States)

Author keywords

Adenylate cyclase; A 25 35; Hippocampus; Long term potentiation; amyloid peptide

Indexed keywords

ADENYLATE CYCLASE; AMYLOID BETA PROTEIN[25-35]; FORSKOLIN; ISOPRENALINE; MAGNESIUM; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN CORTEX; CEREBROSPINAL FLUID; CONFERENCE PAPER; CONTROLLED STUDY; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; RAT; SENILE PLAQUE; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TASK PERFORMANCE; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; FISCHER 344 RAT; METABOLISM; PHYSIOLOGY; SYNAPSE;

ANIMALIA; MUS; RATTUS;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; FORSKOLIN; HIPPOCAMPUS; ISOPROTERENOL; LONG-TERM POTENTIATION; MAGNESIUM; MALE; PEPTIDE FRAGMENTS; RATS; RATS, INBRED F344; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 34247648720     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1379.020     Document Type: Conference Paper

References (14)

1. BACH, M.E., M. BARAD, et al. 1999. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc. Natl. Acad. Sci. USA 96: 5280-5285.
2. REIS, G.F., M.B. LEE, et al. 2005. Adenylate cyclase-mediated forms of synaptic potentiation in hippocampal area CA1 are reduced with aging. J. Neurophysiol. 93: 3381-3389.
3. RASKIN, J.S. & K.D. PARFITT. 2002. Changes with Aging in an Adenylate Cyclase-Mediated Form of Long Term Potentiation in Hippocampal Area CA1. Program Number 444.12, 2002 Abstract Viewer/Itinerary Planner. Society for Neuroscience. Washington DC: CD ROM.
4. MAKHINSON, M., J.K. CHOTINER, et al. 1999. Adenylyl cyclase activation modulates activity-dependent changes in synaptic strength and Ca2+/calmodulin-dependent kinase II autophosphorylation. J. Neurosci. 19: 2500-2510.
5. KUO, S.P., & K.D. PARFITT. 2004. Changes with aging in forskolin-stimulated and basal cyclic AMP in the hippocampus. Program No. 905.5. 2004 Abstract Viewer/Itinerary planner (online). Society for Neuroscience. Washington, DC.
6. PIKE, C.J., A.J. WALENCEWICZ-WASSERMAN, et al. 1995. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J. Neurochem. 64: 253-265.
7. FREIR, D.B., C. HOLSCHER & C.E. HERRON. 2001. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85: 708-713.
8. FREIR, D.B., D.A. COSTELLO & C.E. HERRON. 2003. A-beta25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. J. Neurophysiol. 89: 3061-3069.
9. CHEN, Q.S., B.L. KAGAN, et al. 2000. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J. Neurosci. Res. 60: 65-72.
10. MATTSON, M.P., S.W. BARGER, et al. 1993. Beta-amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16: 409-414.
11. UEDA, K., S. SHINOHARA, et al. 1997. Amyloid β protein potentiates calcium influx through L-type calcium channels: a possible involvement of free radicals. J. Neurochem. 68: 265-271.
12. CHEN, Q.S., W.Z. WEI, T. SHIMAHARA & C.W. XIE. 2002. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 77: 354-371.
13. VITOLO, O.V., A. SANT'ANGELO, V. COSTANZO, et al. Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. USA 99: 13217-13221.
14. MADISON, D.V. & R.A. NICOLL. 1986. Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurones, in vitro. J. Physiol. 372: 221-244.